fifty-three patients with recurrent and advanced stage ( iii and iv ) non-small-cell lung cancer ( nsclc ) were treated with a combination of bleomycin , etoposide ( vp-16-213 ) , and cis-diamminedichloroplatinum ( bep ) .
C0005740
bleomycin
C0053334
bep